期刊文献+

心肌型脂肪酸结合蛋白早期诊断急性冠脉综合征 被引量:11

Heart-type fatty acid-binding protein detection for early diagnosis of acute coronary syndrome
在线阅读 下载PDF
导出
摘要 目的探讨心肌型脂肪酸结合蛋白(H-FABP)在病人出现急性胸痛症状早期区分诊断急性冠脉综合征(ACS)患者与正常人的效果。方法人为纳入正常人、急性心肌梗死(AMI)确诊病人比例2∶1以及正常人、不稳定心绞痛(UAP)确诊病人比例2∶1的小样本人群。采用双抗体夹心ELISA法对40例正常人、19例AMI患者以及20例UAP患者血清H-FABP浓度进行定量。分别绘制H-FABP在正常人、AMI患者组成的人群以及正常人、UAP患者组成的人群中用于诊断AMI和UAP者的特征曲线(ROC曲线)并比较曲线下面积(AUC)与0.5的大小,0.5被认为是确定一项指标是否具有任何诊断意义的AUC临界值。结果H-FABP浓度定量正常人组为(1.29±0.64)ng/ml、AMI组为(24.45±32.40)ng/ml、UAP组为(1.95±3.11)ng/ml,依此绘制出的ROC曲线其AUC分别为AUCAMI:0.978(95%CI:0.948 ̄1.000),AUCUAP:0.503(95%CI:0.334 ̄0.671)。前者与0.5相比具有显著差异而后者没有。结论H-FABP具备在急性胸痛症状出现早期区分AMI与正常人的能力,但不具备早期区分UAP与正常人的能力。H-FABP定量检测可用于AMI早期诊断。 Objective To estimate the reliability of heart-type fatty acid-binding protein (H-FABP) for identifying acute coronary syndrome (ACS) in the early stage of chest pain onset. Methods This investigation was conducted based on a small population consisting of 40 healthy individuals, 19 established AMI patients and 20 unstable angina pectoris (UAP) patients. Serum H-FABP concentrations were measured in these subjects by sandwich ELISA, and receiver operating characteristics (ROC) curves for H-FABP for diagnosing AMI and UAP against normal subjects were then generated respectively. The areas under curve (AUCs) were calculated, and 0.5 was defined as the critical value of AUC to evaluate the diagnostic ability. Resuits The concentrations of H-FABP in healthy individuals, AMI patients and UAP patients were 1.29±0.64, 24.45±32.40 and 1.95±3.11 ng/ml, respectively; AUC AMI and AUC UAP were 0.978 (95 %CI :0.948-1.000) and 0.503 (95 %CI :0.334-0.671) respectively, and the former was significantly greater than 0.5. Conclusions In the early stage of chest pain onset H-FABP detection is sufficient in distinguishing AMI patients from healthy individuals, but not capable of distinguishing UAP patients from healthy individuals. H-FABP may bc used as a diagnostic biochemical marker in the early stage of AMI.
出处 《南方医科大学学报》 CAS CSCD 北大核心 2006年第3期358-360,共3页 Journal of Southern Medical University
关键词 脂肪酸类 心肌梗死 不稳定心绞痛 生化标志物 fatty acids myocardial infarction unstable angina pectoris biochemical marker
  • 相关文献

参考文献12

  • 1李天德.急性冠脉综合征(ACS)诊断与治疗策略的变化[J].岭南心血管病杂志,2002,8(2):88-90. 被引量:5
  • 2Penttila I, Penttila K, Rantanen T, et al. Laboratory diagnosis of patients with acute chest pain [J]. Clin Chem Lab Med, 2000, 38(3):187-97.
  • 3Olukoga A, Donaldson D. An overview of biochemical markers in acute coronary syndromes[J]. J R Soc Health, 2001, 121(2): 103-6.
  • 4Plebani M. Biochemical markers of cardiac damage: from efficiency to effectiveness[J]. Clin Chim Acta, 2001, 311(1): 3-7.
  • 5Mauro Panteghini. Acute coronary syndrome biochemical strategies in the troponin era[J]. Chest, 2002, 122: 1428-35.
  • 6Glatz JF, Storch J. Unravelling the significance of cellular fatty acidbinding proteins[J]. Curt Opin Lipidol, 2001, 12: 267-74.
  • 7Zhou XH, Nancy AO, Donna KM. Statistical methods in diagnostic medicine[M]. New York: Wiley & Sons Inc, 2002:42-51.
  • 8Chan CPY, Sanderson JE, Glanz JFC, et al. A super early myocardial infarction marker-Human heart type fatty acid binding protein[J]. ZKardiol, 2004, 93: 388-97.
  • 9Wodzig KW, Pelsers MM, van der Vusse G J, et al. One-step enzyme-linked immunosorbent assay (ELISA) for plasma fatty acid-binding protein[J]. Ann Clin Biochem, 1997, 34 ( Pt 3): 263-8.
  • 10Schreiber A, Feldbrugge R, Key G, et al. An immunosensor based on disposable electrondes for rapid estimation of fatty acid-binding protein, an earky marker of myocardial infarction [J]. Biosens Bioelectron, 1997, 12:1131-7.

二级参考文献8

  • 1王家良.临床流行病学 第2版[M].上海:上海科学技术出版社,2001.258—269.
  • 2Moore RA. Concepts and principles of evidence-based laboratory medicine [J]. Am Clin Lab, 1999, 18 : 24-25.
  • 3Wennberg DE, Kellett MA, Dickens JD, et al. The association between local diagnotic testing intesity and invasive cardiac procedures [J]. JAMA, 1996, 275:1161-1164.
  • 4Verrilli D, Welch G. The impact of diagnostic testing on therapeutic interventions [J]. JAMA, 1996,275 :1189-1191.
  • 5David LS, Sharon ES, W Scott R, et al. Evidencebased medicine[M]. Second edition. Churchill Livingstone: Harcourt publishers limited,2000.29-66.
  • 6Matthias, George, Douglas. Systematic reviews in health care: meta-analysis in context [ M]. 2nd ed.London: BMJ publishing group. BMA House, 2001.93-125.
  • 7Moses LE, Shapiro D, Littenberg B. Combibing independent studies of a diagnostic test into a summary ROC curve: data-analytic approaches and some additional consideration [J]. Statistics in Medicine, 1993,12 : 1293-1316.
  • 8Irwig L, Macaskill P, Glasziou P, et al. Meta-analytic methods for diagnostic test accuracy[J]. J Clin Epidemiol, 1995,48 : 119-130.

共引文献27

同被引文献99

引证文献11

二级引证文献49

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部